Granules India incorporates wholly owned Brazil subsidiary
In short
Granules India has set up a wholly owned subsidiary in Brazil called Triton Farmaceutica Do Brasil Ltda. The company says it will make, promote, sell and distribute pharmaceutical products there.
This could help Granules expand in Brazil’s drug market. The reporting does not say how much this move costs or when the business will start.
What the reporting says
Granules India has incorporated a wholly owned subsidiary in Brazil, according to the reporting. The new unit, Triton Farmaceutica Do Brasil Ltda, will manufacture, promote, sell and distribute pharmaceuticals and related products in Brazil. The reporting does not state the incorporation date, investment amount, or when operations will begin.
Why it matters
Granules India has incorporated a wholly owned subsidiary in Brazil named Triton Farmaceutica Do Brasil Ltda. The subsidiary is expected to manufacture, promote, sell and distribute pharmaceuticals and related products in Brazil. This is relevant to the company’s overseas expansion and pharmaceutical sales footprint, but the reporting does not provide financial terms or launch timing.